335 related articles for article (PubMed ID: 30517191)
41. Evaluation of FOXP3 expression in canine mammary gland tumours.
Oh SY; Ryu HH; Yoo DY; Hwang IK; Kweon OK; Kim WH
Vet Comp Oncol; 2014 Mar; 12(1):20-8. PubMed ID: 22541038
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
43. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
44. Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas.
Ettlin J; Bauer A; Opitz L; Malbon A; Markkanen E
J Mammary Gland Biol Neoplasia; 2023 Jul; 28(1):14. PubMed ID: 37391533
[TBL] [Abstract][Full Text] [Related]
45. VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study.
Santos A; Lopes C; Gärtner F; Matos AJ
Vet Comp Oncol; 2016 Sep; 14(3):e83-92. PubMed ID: 24976305
[TBL] [Abstract][Full Text] [Related]
46. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
47. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
48. Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary gland.
Datta K; Hyduke DR; Suman S; Moon BH; Johnson MD; Fornace AJ
Radiat Oncol; 2012 Dec; 7():205. PubMed ID: 23216862
[TBL] [Abstract][Full Text] [Related]
49. Preliminary report on the expression of leptin and leptin receptor (ObR) in normal, hyperplastic and neoplastic canine mammary tissues.
Ressel L; Finotello R; Innocenti VM; Vannozzi I; Poli A
Res Vet Sci; 2012 Aug; 93(1):343-9. PubMed ID: 21875727
[TBL] [Abstract][Full Text] [Related]
50. Carnitine palmitoyltransferase 1 A expression profile in canine mammary tumors.
Cacciola NA; Sgadari M; Petillo O; Margarucci S; Martano M; Cocchia N; Maiolino P; Restucci B
Vet J; 2020 Mar; 257():105453. PubMed ID: 32546357
[TBL] [Abstract][Full Text] [Related]
51. Downregulation of ATM Gene and Protein Expression in Canine Mammary Tumors.
Raposo-Ferreira TM; Bueno RC; Terra EM; Avante ML; Tinucci-Costa M; Carvalho M; Cassali GD; Linde SD; Rogatto SR; Laufer-Amorim R
Vet Pathol; 2016 Nov; 53(6):1154-1159. PubMed ID: 27106737
[TBL] [Abstract][Full Text] [Related]
52. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
53. Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours: part 1. Proliferation, apoptosis and DNA repair.
Matos AJ; Santos AA
Vet J; 2015 Aug; 205(2):136-43. PubMed ID: 25744808
[TBL] [Abstract][Full Text] [Related]
54. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical study of IGF-I and IGF-II expression in canine mammary tumours: Prognostic and diagnostic role.
Ozmen O
Acta Vet Hung; 2020 Sep; 68(3):269-274. PubMed ID: 33221734
[TBL] [Abstract][Full Text] [Related]
56. Expression and prognostic value of TRPM7 in canine mammary tumours.
Lee S; Lee S; Kim WH
Vet Comp Oncol; 2021 Sep; 19(3):510-517. PubMed ID: 33617107
[TBL] [Abstract][Full Text] [Related]
57. SFRP1 Expression is Inversely Associated With Metastasis Formation in Canine Mammary Tumours.
Seitz J; Bilsland A; Puget C; Baasner I; Klopfleisch R; Stein T
J Mammary Gland Biol Neoplasia; 2023 Jul; 28(1):15. PubMed ID: 37402051
[TBL] [Abstract][Full Text] [Related]
58. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
[TBL] [Abstract][Full Text] [Related]
60. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]